FDA Clears Advanced Test For Monitoring Metastatic Colorectal Cancer

Veridex, LLC announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch™ System to be used as an aid in the monitoring of metastatic colorectal cancer. CellSearch™ is currently approved for monitoring metastatic breast cancer.The CellSearch™ System identifies and counts circulating tumor cells (CTCs) in a blood sample to predict progression-free survival and overall survival in patients with metastatic colorectal or breast cancer, and can do so earlier than the current standard of care. The results of serial testing for CTCs with the CellSearch™ System, in conjunction with other clinical methods for monitoring, can help physicians assess disease progression, thereby guiding more informed care decisions earlier.

read the full article: http://www.medicalnewstoday.com/articles/89671.php